{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:56:54Z","timestamp":1793912214849,"version":"4.8.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to evaluate the indeterminate rate of interferon gamma release assays (IGRAs) in the detection of latent tuberculosis infection (LTBI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>On 15 November 2022, we searched the PubMed\u00ae (National Library of Medicine, Bethesda, MD, USA), Embase\u00ae (Elsevier, Amsterdam, the Netherlands), and Cochrane Library databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two investigators independently extracted the study data and assessed their quality using a modified quality assessment of diagnostic accuracy studies (i.e., QUADAS-2) tool. A random-effects model was used to calculate pooled results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 403 studies involving 486,886 individuals and found that the pooled indeterminate rate was 3.9% (95% CI 3.5%\u20134.2%). The pooled indeterminate rate for QuantiFERON\u00ae-TB (QFT) was similar to that for T-SPOT\u00ae.TB (T-SPOT) [odds ratio (OR)\u00a0=\u00a00.88, 95% CI 0.59\u20131.32]; however, the indeterminate rate for a new generation of QFT (QFT-plus) was lower than that of T-SPOT (OR\u00a0=\u00a00.24, 95% CI 0.16\u20130.35). The indeterminate rate in the immunocompromised population was significantly higher than that in healthy controls (OR\u00a0=\u00a03.51, 95% CI 2.11\u20135.82), and it increased with the reduction of CD4+ cell count in HIV-positive patients. Children\u2019s pooled indeterminate rates (OR\u00a0=\u00a02.56, 95% CI 1.79\u20133.57) were significantly higher than those of adults, and the rates increased as the children\u2019s age decreased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>On average, 1 in 26 tests yields indeterminate IGRA results in LTBI screening. The use of advanced versions of the QuantiFERON-TB assay (QFT-plus), may potentially reduce the occurrence of an indeterminate result. Our study emphasizes the high risk of immunosuppression and young age in relation to indeterminate IGRA, which should receive more attention in the management of LTBI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>PROSPERO <jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020211363<\/jats:uri>, CRD42020211363.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1170579","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:29:27Z","timestamp":1684153767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Guozhong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanse","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","unstructured":"Global tuberculosis report 2020"},{"key":"B2","unstructured":"GenevaWorld Health OrganizationLatent TB infection: updated and consolidated guidelines for programmatic management2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"B5","article-title":"Position statement on interferon-\u03b3 release assays in the detection of latent tuberculosis infection","volume":"36","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"key":"B6","unstructured":"Latent tuberculosis infection: a guide for primary health care providers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"B8","article-title":"Position statement on interferon-\u03b3 release assays for the detection of latent tuberculosis infection","volume":"41","author":"Bastian","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1701267","DOI":"10.1183\/13993003.01267-2017","article-title":"Frequency and significance of indeterminate and borderline quantiferon gold TB IGRA results","volume":"50","author":"Brown","year":"2017","journal-title":"Eur Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12879-016-1687-8","article-title":"Accuracy of the interferon-\u03b3 release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis","volume":"16","author":"Huo","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/jpm12030507","article-title":"Impact of immunosuppressive therapy on the performance of latent tuberculosis screening tests in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Park","year":"2022","journal-title":"J Pers Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2018.09.040","article-title":"Prevalence of latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis","volume":"125","author":"Rahimifard","year":"2018","journal-title":"Microb Pathog"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00208","article-title":"Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-a systematic review and meta-analysis","volume":"7","author":"Meier","year":"2019","journal-title":"Front Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-p) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m549","article-title":"Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109132","article-title":"Positive rates of interferon-\u03b3 release assay and tuberculin skin test in detection of latent tuberculosis infection: a systematic review and meta-analysis of 200,000 head-to-head comparative tests","volume":"245","author":"Zhou","year":"2022","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2010.12960","article-title":"Assessment of an interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient","volume":"140","author":"Hoffmann","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. rating the quality of evidence\u2013publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12874-018-0495-9","article-title":"Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations","volume":"18","author":"Mueller","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"B25","unstructured":"The end TB strategy 2014"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01547-13","article-title":"Significant reduction in rate of indeterminate results of the QuantiFERON-TB gold in-tube test by shortening incubation delay","volume":"52","author":"Yun","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2983","article-title":"Interferon-\u03b3 release assays for diagnosis of tuberculosis infection and disease in children","volume":"134","author":"Starke","year":"2014","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13087","article-title":"High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates","volume":"21","author":"Wigg","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1086\/644754","article-title":"Prospective comparison of tuberculin skin test and QuantiFERON-TB gold in-tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting","volume":"30","author":"Cummings","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/jpids\/piu024","article-title":"Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic","volume":"4","author":"Rose","year":"2015","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2011.02.001","article-title":"Indeterminate results of QuantiFERON-TB gold in-tube assay in nonimmunosuppressed children","volume":"42","author":"Zrinski Topi\u0107","year":"2011","journal-title":"Arch Med Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09128-6","article-title":"Heterophilic antibodies influence immunometric assay: a case report and reviews","volume":"68","author":"Hu","year":"2020","journal-title":"Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3109\/08916930109014694","article-title":"Heterophile antibodies indicate progression of autoimmunity in human type 1 diabetes mellitus before clinical onset","volume":"34","author":"Orban","year":"2001","journal-title":"Autoimmunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1170579\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:29:32Z","timestamp":1684153772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1170579\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2023.1170579"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1170579","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1170579"}}